A Study Testing the Superiority of CHF 1535 pMDI 800/24µg Total Daily Dose Compared With CHF 718 pMDI 800µg Total Daily Dose in Adults With Asthma on Medium or High-Dose Inhaled Corticosteroid
Clinical trial NCT05292586 · COMPLETED
Trial details
- NCT number
- NCT05292586
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-31
- Primary completion
- 2024-06-24
- Enrollment
- 1377
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.